PTPRC and familial pancreatic carcinoma: Moreover, the population of MDSCs (Gr1+Cd11b+Cd45+), which are known to be significantly expanded and contribute to ineffective therapies in pancreatic cancer (31), was decreased in KPC tumors receiving Irg1−/− macrophages (Fig. 7D).